IRIS
BRUNETTI, LEONARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.411
AS - Asia 939
EU - Europa 779
SA - Sud America 239
AF - Africa 34
OC - Oceania 3
Totale 3.405
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.362
SG - Singapore 401
BR - Brasile 215
CN - Cina 197
IT - Italia 186
RU - Federazione Russa 157
HK - Hong Kong 133
SE - Svezia 102
DE - Germania 82
VN - Vietnam 65
GB - Regno Unito 59
FR - Francia 54
IN - India 49
AT - Austria 38
ID - Indonesia 26
CA - Canada 25
FI - Finlandia 19
CI - Costa d'Avorio 14
PL - Polonia 14
MX - Messico 13
JP - Giappone 12
BE - Belgio 11
NL - Olanda 11
AR - Argentina 10
BD - Bangladesh 10
TR - Turchia 10
LT - Lituania 9
TW - Taiwan 9
ZA - Sudafrica 9
ES - Italia 6
KR - Corea 5
AL - Albania 4
CH - Svizzera 4
EC - Ecuador 4
EE - Estonia 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
JM - Giamaica 3
BH - Bahrain 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
IE - Irlanda 2
IL - Israele 2
IQ - Iraq 2
KE - Kenya 2
PY - Paraguay 2
TH - Thailandia 2
VE - Venezuela 2
BB - Barbados 1
BN - Brunei Darussalam 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 3.405
Salva come PNG Salva come JPEG
Città #
Ashburn 226
Singapore 203
Chandler 174
Hong Kong 125
Nyköping 96
Beijing 86
Fairfield 81
Cambridge 51
Dallas 51
Bari 40
New York 40
Houston 39
Los Angeles 37
Seattle 37
Munich 34
Woodbridge 30
Wilmington 28
Naples 27
Jakarta 25
Ho Chi Minh City 24
Moscow 22
Langenzersdorf 21
Lawrence 21
Fragagnano 20
North Bergen 20
Roxbury 19
São Paulo 17
Inglewood 16
Marseille 16
Helsinki 15
London 15
Abidjan 14
Santa Clara 14
Brooklyn 13
Frankfurt am Main 13
Hanoi 13
Milan 13
Ann Arbor 12
Chicago 12
Council Bluffs 12
Atlanta 11
Warsaw 11
Brussels 10
Chennai 10
Falkenstein 10
Nuremberg 10
Poplar 10
San Francisco 10
Boydton 9
Buffalo 9
Denver 9
Des Moines 9
Montreal 9
Redondo Beach 9
Rome 9
Tokyo 9
Johannesburg 8
Rio de Janeiro 8
Düsseldorf 7
Guangzhou 7
Kolkata 7
Patna 7
Shanghai 7
Vienna 7
Paris 6
Toronto 6
Wuxi 6
Amsterdam 5
Bitonto 5
Boston 5
Brasília 5
Brindisi 5
Dong Ket 5
Lauterbourg 5
Orem 5
Portsmouth 5
Shenzhen 5
Taichung 5
Ankara 4
Belo Horizonte 4
Mexico City 4
Phoenix 4
Pune 4
Salerno 4
Stockholm 4
The Dalles 4
Turku 4
Washington 4
West Jordan 4
Wuhan 4
Bhubaneswar 3
Boardman 3
Bucha 3
Campina Grande 3
Campinas 3
Carney 3
Chang-hua 3
Charlotte 3
Columbus 3
Curitiba 3
Totale 2.135
Salva come PNG Salva come JPEG
Nome #
A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders 142
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 136
Bone-seeking matrix metalloproteinase inhibitors for the treatment of skeletal malignancy 133
New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation 132
DEVELOPMENT OF PHENOXYALKYLPIPERIDINES AS HIGH-AFFINITY SIGMA-1 (s1) RECEPTOR LIGANDS WITH POTENT ANTI-AMNESIC ACTIVITY 119
Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease 118
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 117
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 108
Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2‐Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil‐Like Compounds 105
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 105
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents 103
A Chemoinformatics Search for Peroxisome Proliferator-Activated Receptors Ligands Revealed a New Pan-Agonist Able to Reduce Lipid Accumulation and Improve Insulin Sensitivity 96
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 94
Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey 86
A NEW ANTIDIABETIC AGENT SHOWING PPARα/γ DUAL AGONISM AND MITOCHONDRIAL PYRUVATE CARRIER INHIBITION 83
A Chemical Modification of a Peroxisome Proliferator-Activated Receptor Pan Agonist Produced a Shift to a New Dual Alpha/Gamma Partial Agonist Endowed with Mitochondrial Pyruvate Carrier Inhibition and Antidiabetic Properties 82
Natural compounds as FAAH inhibitors: preliminary screening and potential developments 82
Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase 81
FPR2 and brimstone: a novel approach for the treatment of neuroinflammation 79
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases 78
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition 76
Identification of Natural Scaffolds as New Multi-Functional Agents for the Treatment of Alzheimer’s Disease 75
Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect 72
Can foods influence the onset and progress of neurodegenerative diseases? 71
IDENTIFICATION OF A NOVEL PPARRα/γ DUAL AGONIST SHOWING ANTIDIABETIC EFFECTS AND ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF PPARγ 69
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 69
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 68
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding 67
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 63
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy 63
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases 63
Novel small molecules for PPARs modulation and their potential use for treatment of metabolic disorders 63
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 57
Discovery of a dual PPARα/γ partial agonist displaying antisteatotic and antidiabetic properties: in silico studies and X-ray structure determination 55
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 54
New rivastigmine-like compounds for the potential treatment of Alzheimer’s disease: a multi-target approach 52
From classical MTDLs to a semi-synthetic innovative green approach: nature-inspired design as a new intriguing opportunity for new anti-Alzheimer’s drugs 51
Peroxisome Proliferator Activated Receptor (PPAR) agonists as Fatty Acid Amide Hydrolase (FAAH) inhibitors: screening and preliminary structure-activity relationships 51
Rivastigmine-based hybrids: a multi-target approach to anti-Alzheimer’s drug design 46
The pivotal role of pyrrolidine ring as multitarget scaffold in neurodegenerative diseases 45
New phenothiazine-donepezil like hybrids as potential Alzheimer’s disease multitarget drugs with antioxidant properties 42
Role of copper chelating agents: between old applications and new perspectives in neuroscience 36
Tackling neuroinflammation with H2S releasing FPR2 agonists 30
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases 27
Novel Rivastigmine-Based Multitarget Hybrids For Potential Treatment of Alzheimer’s Disease: Cu(II) And Fe(III) Chelation Studies 24
Novel rivastigmine structure-based hybrids for the potential treatment of Alzheimer’s disease 24
Design, Synthesis, and Biological Evaluation of Novel Heteroaryl, Squaramide, and Indolcarboxamide Derivatives as Formyl Peptide Receptor 2 Agonists to Target Neuroinflammation 23
Multitarget 5-HT6R/FAAH/ChE ligands: the future of Alzheimer’s Disease treatment? 22
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease 22
A new potent and selective peroxisome proliferator-activated receptor alpha partial agonist displays anti-steatotic effects In vitro and behaves as a safe hypolipidemic and hypoglycemic agent in a diabetic mouse model 17
Hydrogen Sulfide (H2S)-Donating Formyl Peptide Receptor 2 (FPR2) Agonists: Design, Synthesis, and Biological Evaluation in Primary Mouse Microglia Culture 13
The first-in-class 1,3,5-triazine-derived dual 5-HT6R/FAAH modulators in search for potential drug against neurodegenerative diseases with cognitive impairment 8
Totale 3.597
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.661
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 6 42 13 11 45 12 13
2021/2022152 10 6 2 1 0 13 3 5 13 14 26 59
2022/2023418 33 61 36 33 32 52 7 57 68 9 19 11
2023/2024241 14 22 15 12 21 56 12 2 17 23 17 30
2024/20251.176 79 42 70 63 53 63 173 120 69 80 124 240
2025/20261.251 331 155 173 295 272 25 0 0 0 0 0 0
Totale 3.597